60 Degrees Pharmaceuticals, Inc.
SXTP
$1.63
-$0.08-4.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.24% | 256.92% | 144.95% | 89.43% | 537.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.24% | 256.92% | 144.95% | 89.43% | 537.47% |
| Cost of Revenue | 2.20% | -24.45% | -90.58% | 19.45% | 146.70% |
| Gross Profit | 26.91% | 98.39% | 100.26% | 15.97% | -47.83% |
| SG&A Expenses | -8.18% | 23.99% | 42.78% | 56.85% | -5.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.44% | 25.91% | -55.67% | 46.65% | 20.68% |
| Operating Income | 7.16% | -9.76% | 61.69% | -42.35% | -9.03% |
| Income Before Tax | 29.70% | -7.25% | 58.47% | -538.60% | -0.17% |
| Income Tax Expenses | -125.00% | 0.00% | 275.00% | 0.00% | -900.00% |
| Earnings from Continuing Operations | 29.76% | -7.24% | 58.44% | -538.62% | -0.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -87.18% | 0.00% | -20.00% | -68.00% | -88.50% |
| Net Income | 29.65% | -7.25% | 58.45% | -535.89% | -1.63% |
| EBIT | 7.16% | -9.76% | 61.69% | -42.35% | -9.03% |
| EBITDA | 7.59% | -9.44% | 62.06% | -42.01% | -8.79% |
| EPS Basic | 83.86% | 85.72% | 94.02% | -183.90% | 89.64% |
| Normalized Basic EPS | 84.20% | 85.74% | 94.28% | -157.10% | 89.33% |
| EPS Diluted | 83.86% | 85.72% | 94.02% | -183.90% | 89.64% |
| Normalized Diluted EPS | 84.20% | 85.74% | 94.28% | -157.10% | 89.33% |
| Average Basic Shares Outstanding | 346.15% | 651.96% | 626.23% | 660.43% | 883.54% |
| Average Diluted Shares Outstanding | 346.15% | 651.96% | 626.23% | 660.43% | 883.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |